nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—Topoisomerase Inhibitors—Teniposide—lung cancer	0.111	0.308	CiPCiCtD
Doxorubicin—Topoisomerase Inhibitors—Topotecan—lung cancer	0.0985	0.275	CiPCiCtD
Doxorubicin—Topoisomerase Inhibitors—Irinotecan—lung cancer	0.0838	0.234	CiPCiCtD
Doxorubicin—Topoisomerase Inhibitors—Etoposide—lung cancer	0.0658	0.183	CiPCiCtD
Doxorubicin—NQO1—lung cancer	0.0474	0.376	CbGaD
Doxorubicin—ABCC3—lung cancer	0.0466	0.37	CbGaD
Doxorubicin—thyroid cancer—lung cancer	0.0454	0.198	CtDrD
Doxorubicin—liver cancer—lung cancer	0.0438	0.191	CtDrD
Doxorubicin—bone cancer—lung cancer	0.0336	0.147	CtDrD
Doxorubicin—muscle cancer—lung cancer	0.0297	0.13	CtDrD
Doxorubicin—testicular cancer—lung cancer	0.0279	0.122	CtDrD
Doxorubicin—kidney cancer—lung cancer	0.0249	0.109	CtDrD
Doxorubicin—sarcoma—lung cancer	0.0237	0.104	CtDrD
Doxorubicin—ABCG2—lung cancer	0.0226	0.18	CbGaD
Doxorubicin—AURKA—Crizotinib—lung cancer	0.0222	0.127	CbGbCtD
Doxorubicin—ABCC6—Teniposide—lung cancer	0.0134	0.0766	CbGbCtD
Doxorubicin—ABCB1—lung cancer	0.00943	0.0747	CbGaD
Doxorubicin—NQO1—Cisplatin—lung cancer	0.00719	0.0411	CbGbCtD
Doxorubicin—TOP2A—Teniposide—lung cancer	0.00713	0.0408	CbGbCtD
Doxorubicin—ABCC6—Vinblastine—lung cancer	0.00656	0.0375	CbGbCtD
Doxorubicin—ABCC10—Gemcitabine—lung cancer	0.00632	0.0362	CbGbCtD
Doxorubicin—ABCC6—Cisplatin—lung cancer	0.00601	0.0344	CbGbCtD
Doxorubicin—ABCC6—Etoposide—lung cancer	0.00591	0.0338	CbGbCtD
Doxorubicin—ABCC10—Paclitaxel—lung cancer	0.00571	0.0327	CbGbCtD
Doxorubicin—ABCC10—Etoposide—lung cancer	0.00451	0.0258	CbGbCtD
Doxorubicin—ABCC10—Docetaxel—lung cancer	0.00413	0.0236	CbGbCtD
Doxorubicin—XDH—Cisplatin—lung cancer	0.00376	0.0215	CbGbCtD
Doxorubicin—CYP1B1—Erlotinib—lung cancer	0.00339	0.0194	CbGbCtD
Doxorubicin—TOP2A—Etoposide—lung cancer	0.00314	0.018	CbGbCtD
Doxorubicin—CYP1B1—Paclitaxel—lung cancer	0.0031	0.0178	CbGbCtD
Doxorubicin—ABCB11—Paclitaxel—lung cancer	0.0031	0.0178	CbGbCtD
Doxorubicin—ABCC10—Methotrexate—lung cancer	0.00298	0.0171	CbGbCtD
Doxorubicin—ABCG2—Topotecan—lung cancer	0.00298	0.0171	CbGbCtD
Doxorubicin—ABCC3—Cisplatin—lung cancer	0.00289	0.0165	CbGbCtD
Doxorubicin—ABCC3—Etoposide—lung cancer	0.00284	0.0162	CbGbCtD
Doxorubicin—ABCG2—Gefitinib—lung cancer	0.00273	0.0156	CbGbCtD
Doxorubicin—ABCB11—Vinblastine—lung cancer	0.00272	0.0156	CbGbCtD
Doxorubicin—ABCG2—Teniposide—lung cancer	0.00264	0.0151	CbGbCtD
Doxorubicin—CYP1B1—Docetaxel—lung cancer	0.00224	0.0128	CbGbCtD
Doxorubicin—ABCC1—Paclitaxel—lung cancer	0.00221	0.0126	CbGbCtD
Doxorubicin—ABCC1—Irinotecan—lung cancer	0.00218	0.0124	CbGbCtD
Doxorubicin—ABCC1—Vinblastine—lung cancer	0.00193	0.0111	CbGbCtD
Doxorubicin—ABCC3—Methotrexate—lung cancer	0.00188	0.0107	CbGbCtD
Doxorubicin—ABCC1—Etoposide—lung cancer	0.00174	0.00997	CbGbCtD
Doxorubicin—ABCC2—Paclitaxel—lung cancer	0.00163	0.00934	CbGbCtD
Doxorubicin—ABCG2—Erlotinib—lung cancer	0.00161	0.00922	CbGbCtD
Doxorubicin—ABCC2—Irinotecan—lung cancer	0.00161	0.00921	CbGbCtD
Doxorubicin—ABCC1—Docetaxel—lung cancer	0.00159	0.00912	CbGbCtD
Doxorubicin—ABCG2—Paclitaxel—lung cancer	0.00148	0.00844	CbGbCtD
Doxorubicin—ABCG2—Irinotecan—lung cancer	0.00146	0.00833	CbGbCtD
Doxorubicin—ABCC2—Vinblastine—lung cancer	0.00143	0.00819	CbGbCtD
Doxorubicin—ABCC2—Cisplatin—lung cancer	0.00131	0.00751	CbGbCtD
Doxorubicin—ABCC2—Etoposide—lung cancer	0.00129	0.00738	CbGbCtD
Doxorubicin—ABCG2—Cisplatin—lung cancer	0.00119	0.00679	CbGbCtD
Doxorubicin—ABCC2—Docetaxel—lung cancer	0.00118	0.00675	CbGbCtD
Doxorubicin—ABCG2—Etoposide—lung cancer	0.00117	0.00667	CbGbCtD
Doxorubicin—ABCC1—Methotrexate—lung cancer	0.00115	0.00659	CbGbCtD
Doxorubicin—NOS3—pulmonary artery—lung cancer	0.00113	0.0552	CbGeAlD
Doxorubicin—ABCB1—Topotecan—lung cancer	0.00108	0.00615	CbGbCtD
Doxorubicin—ABCG2—Docetaxel—lung cancer	0.00107	0.0061	CbGbCtD
Doxorubicin—CYP2B6—Irinotecan—lung cancer	0.00102	0.00586	CbGbCtD
Doxorubicin—ABCB1—Gefitinib—lung cancer	0.000983	0.00562	CbGbCtD
Doxorubicin—CYP2D6—Gefitinib—lung cancer	0.000927	0.0053	CbGbCtD
Doxorubicin—ABCC2—Methotrexate—lung cancer	0.000852	0.00488	CbGbCtD
Doxorubicin—CYP2B6—Cisplatin—lung cancer	0.000835	0.00478	CbGbCtD
Doxorubicin—ABCG2—Methotrexate—lung cancer	0.000771	0.00441	CbGbCtD
Doxorubicin—ABCB1—Vinorelbine—lung cancer	0.000757	0.00433	CbGbCtD
Doxorubicin—NOS3—umbilical vein—lung cancer	0.000746	0.0364	CbGeAlD
Doxorubicin—CYP2D6—Vinorelbine—lung cancer	0.000714	0.00408	CbGbCtD
Doxorubicin—CYP3A4—Topotecan—lung cancer	0.000644	0.00368	CbGbCtD
Doxorubicin—ABCB1—Crizotinib—lung cancer	0.000603	0.00345	CbGbCtD
Doxorubicin—CYP3A4—Gefitinib—lung cancer	0.000589	0.00337	CbGbCtD
Doxorubicin—ABCB1—Gemcitabine—lung cancer	0.000589	0.00337	CbGbCtD
Doxorubicin—ABCB1—Erlotinib—lung cancer	0.000581	0.00333	CbGbCtD
Doxorubicin—CYP3A4—Teniposide—lung cancer	0.000571	0.00327	CbGbCtD
Doxorubicin—CYP2D6—Erlotinib—lung cancer	0.000548	0.00313	CbGbCtD
Doxorubicin—ABCB1—Paclitaxel—lung cancer	0.000532	0.00304	CbGbCtD
Doxorubicin—ABCB1—Irinotecan—lung cancer	0.000525	0.003	CbGbCtD
Doxorubicin—AKR1A1—mammary gland—lung cancer	0.000494	0.0242	CbGeAlD
Doxorubicin—ABCB1—Vinblastine—lung cancer	0.000467	0.00267	CbGbCtD
Doxorubicin—CYP3A4—Vinorelbine—lung cancer	0.000454	0.0026	CbGbCtD
Doxorubicin—CYP2D6—Vinblastine—lung cancer	0.00044	0.00252	CbGbCtD
Doxorubicin—ABCB1—Cisplatin—lung cancer	0.000428	0.00245	CbGbCtD
Doxorubicin—ABCB1—Etoposide—lung cancer	0.000421	0.00241	CbGbCtD
Doxorubicin—AURKA—mammary gland—lung cancer	0.000418	0.0204	CbGeAlD
Doxorubicin—ABCB1—Docetaxel—lung cancer	0.000385	0.0022	CbGbCtD
Doxorubicin—CYP3A4—Crizotinib—lung cancer	0.000361	0.00207	CbGbCtD
Doxorubicin—CBR3—bronchus—lung cancer	0.000351	0.0172	CbGeAlD
Doxorubicin—DHCR7—mammary gland—lung cancer	0.000349	0.0171	CbGeAlD
Doxorubicin—CYP3A4—Erlotinib—lung cancer	0.000348	0.00199	CbGbCtD
Doxorubicin—SLC22A16—bone marrow—lung cancer	0.000334	0.0163	CbGeAlD
Doxorubicin—AKR1A1—respiratory system—lung cancer	0.00033	0.0161	CbGeAlD
Doxorubicin—YWHAG—mammary gland—lung cancer	0.000321	0.0157	CbGeAlD
Doxorubicin—CYP3A4—Paclitaxel—lung cancer	0.000319	0.00182	CbGbCtD
Doxorubicin—CBR3—trachea—lung cancer	0.000315	0.0154	CbGeAlD
Doxorubicin—CYP3A4—Irinotecan—lung cancer	0.000315	0.0018	CbGbCtD
Doxorubicin—NOS3—mammary gland—lung cancer	0.000285	0.0139	CbGeAlD
Doxorubicin—CYP3A4—Vinblastine—lung cancer	0.00028	0.0016	CbGbCtD
Doxorubicin—ABCB1—Methotrexate—lung cancer	0.000278	0.00159	CbGbCtD
Doxorubicin—AKR1A1—bronchus—lung cancer	0.000271	0.0133	CbGeAlD
Doxorubicin—CBR1—mammary gland—lung cancer	0.00027	0.0132	CbGeAlD
Doxorubicin—CYP3A4—Etoposide—lung cancer	0.000252	0.00144	CbGbCtD
Doxorubicin—NOS1—respiratory system—lung cancer	0.00025	0.0122	CbGeAlD
Doxorubicin—NDUFS2—respiratory system—lung cancer	0.000248	0.0121	CbGeAlD
Doxorubicin—NDUFS7—bronchus—lung cancer	0.000246	0.012	CbGeAlD
Doxorubicin—NDUFS3—respiratory system—lung cancer	0.000245	0.012	CbGeAlD
Doxorubicin—AKR1A1—trachea—lung cancer	0.000244	0.0119	CbGeAlD
Doxorubicin—ABCB8—lung—lung cancer	0.000235	0.0115	CbGeAlD
Doxorubicin—CYP3A4—Docetaxel—lung cancer	0.000231	0.00132	CbGbCtD
Doxorubicin—AKR1A1—cardiac atrium—lung cancer	0.000229	0.0112	CbGeAlD
Doxorubicin—CBR3—lung—lung cancer	0.000227	0.0111	CbGeAlD
Doxorubicin—NQO1—mammary gland—lung cancer	0.000217	0.0106	CbGeAlD
Doxorubicin—YWHAG—respiratory system—lung cancer	0.000214	0.0104	CbGeAlD
Doxorubicin—NOS1—epithelium—lung cancer	0.000209	0.0102	CbGeAlD
Doxorubicin—NDUFS7—cardiac atrium—lung cancer	0.000208	0.0102	CbGeAlD
Doxorubicin—NDUFS2—bronchus—lung cancer	0.000204	0.00998	CbGeAlD
Doxorubicin—NDUFS3—bronchus—lung cancer	0.000202	0.00986	CbGeAlD
Doxorubicin—AKR1A1—bone marrow—lung cancer	0.000193	0.00944	CbGeAlD
Doxorubicin—RALBP1—respiratory system—lung cancer	0.000193	0.00943	CbGeAlD
Doxorubicin—DHCR7—bronchus—lung cancer	0.000192	0.00937	CbGeAlD
Doxorubicin—NOS3—respiratory system—lung cancer	0.00019	0.00928	CbGeAlD
Doxorubicin—NDUFS2—trachea—lung cancer	0.000183	0.00896	CbGeAlD
Doxorubicin—NDUFS3—trachea—lung cancer	0.000181	0.00885	CbGeAlD
Doxorubicin—CBR1—respiratory system—lung cancer	0.00018	0.00881	CbGeAlD
Doxorubicin—YWHAG—bronchus—lung cancer	0.000176	0.0086	CbGeAlD
Doxorubicin—NDUFS7—bone marrow—lung cancer	0.000176	0.00858	CbGeAlD
Doxorubicin—AKR1A1—lung—lung cancer	0.000175	0.00855	CbGeAlD
Doxorubicin—NDUFS2—cardiac atrium—lung cancer	0.000172	0.00842	CbGeAlD
Doxorubicin—DHCR7—trachea—lung cancer	0.000172	0.00841	CbGeAlD
Doxorubicin—NDUFS3—cardiac atrium—lung cancer	0.00017	0.00832	CbGeAlD
Doxorubicin—AURKA—bone marrow—lung cancer	0.000163	0.00798	CbGeAlD
Doxorubicin—POR—respiratory system—lung cancer	0.000162	0.00794	CbGeAlD
Doxorubicin—DHCR7—cardiac atrium—lung cancer	0.000162	0.0079	CbGeAlD
Doxorubicin—ABCB8—lymph node—lung cancer	0.000161	0.00787	CbGeAlD
Doxorubicin—NDUFS7—lung—lung cancer	0.000159	0.00777	CbGeAlD
Doxorubicin—RALBP1—bronchus—lung cancer	0.000159	0.00776	CbGeAlD
Doxorubicin—NOS3—epithelium—lung cancer	0.000159	0.00775	CbGeAlD
Doxorubicin—YWHAG—trachea—lung cancer	0.000158	0.00772	CbGeAlD
Doxorubicin—CBR3—lymph node—lung cancer	0.000155	0.00758	CbGeAlD
Doxorubicin—CYP1B1—mammary gland—lung cancer	0.000152	0.00743	CbGeAlD
Doxorubicin—YWHAG—cardiac atrium—lung cancer	0.000148	0.00725	CbGeAlD
Doxorubicin—CBR1—bronchus—lung cancer	0.000148	0.00725	CbGeAlD
Doxorubicin—AURKA—lung—lung cancer	0.000148	0.00723	CbGeAlD
Doxorubicin—AKR1C3—bronchus—lung cancer	0.000146	0.00716	CbGeAlD
Doxorubicin—NDUFS2—bone marrow—lung cancer	0.000145	0.00711	CbGeAlD
Doxorubicin—NQO1—respiratory system—lung cancer	0.000144	0.00706	CbGeAlD
Doxorubicin—NDUFS3—bone marrow—lung cancer	0.000144	0.00702	CbGeAlD
Doxorubicin—RALBP1—trachea—lung cancer	0.000143	0.00697	CbGeAlD
Doxorubicin—NOS3—trachea—lung cancer	0.00014	0.00686	CbGeAlD
Doxorubicin—DHCR7—bone marrow—lung cancer	0.000137	0.00667	CbGeAlD
Doxorubicin—RALBP1—cardiac atrium—lung cancer	0.000134	0.00655	CbGeAlD
Doxorubicin—POR—bronchus—lung cancer	0.000134	0.00654	CbGeAlD
Doxorubicin—CBR1—trachea—lung cancer	0.000133	0.00651	CbGeAlD
Doxorubicin—Daunorubicin—ABCG2—lung cancer	0.000133	0.455	CrCbGaD
Doxorubicin—NOS1—lung—lung cancer	0.000133	0.00648	CbGeAlD
Doxorubicin—NDUFS2—lung—lung cancer	0.000132	0.00644	CbGeAlD
Doxorubicin—AKR1C3—trachea—lung cancer	0.000131	0.00643	CbGeAlD
Doxorubicin—NDUFS3—lung—lung cancer	0.00013	0.00636	CbGeAlD
Doxorubicin—ABCC3—respiratory system—lung cancer	0.00013	0.00633	CbGeAlD
Doxorubicin—YWHAG—bone marrow—lung cancer	0.000125	0.00612	CbGeAlD
Doxorubicin—CBR1—cardiac atrium—lung cancer	0.000125	0.00611	CbGeAlD
Doxorubicin—TOP2A—bronchus—lung cancer	0.000125	0.00609	CbGeAlD
Doxorubicin—DHCR7—lung—lung cancer	0.000124	0.00604	CbGeAlD
Doxorubicin—AKR1C3—cardiac atrium—lung cancer	0.000124	0.00604	CbGeAlD
Doxorubicin—NQO1—epithelium—lung cancer	0.000121	0.0059	CbGeAlD
Doxorubicin—ABCC6—lung—lung cancer	0.000121	0.00589	CbGeAlD
Doxorubicin—POR—trachea—lung cancer	0.00012	0.00587	CbGeAlD
Doxorubicin—AKR1A1—lymph node—lung cancer	0.00012	0.00585	CbGeAlD
Doxorubicin—NQO1—bronchus—lung cancer	0.000119	0.00581	CbGeAlD
Doxorubicin—YWHAG—lung—lung cancer	0.000113	0.00555	CbGeAlD
Doxorubicin—RALBP1—bone marrow—lung cancer	0.000113	0.00553	CbGeAlD
Doxorubicin—POR—cardiac atrium—lung cancer	0.000113	0.00551	CbGeAlD
Doxorubicin—NDUFS7—lymph node—lung cancer	0.000109	0.00532	CbGeAlD
Doxorubicin—NQO1—trachea—lung cancer	0.000107	0.00521	CbGeAlD
Doxorubicin—ABCC10—bronchus—lung cancer	0.000106	0.00519	CbGeAlD
Doxorubicin—CBR1—bone marrow—lung cancer	0.000106	0.00516	CbGeAlD
Doxorubicin—AKR1C3—bone marrow—lung cancer	0.000104	0.0051	CbGeAlD
Doxorubicin—Daunorubicin—CYP1A1—lung cancer	0.000104	0.356	CrCbGaD
Doxorubicin—RALBP1—lung—lung cancer	0.000102	0.00501	CbGeAlD
Doxorubicin—CYP1B1—respiratory system—lung cancer	0.000101	0.00495	CbGeAlD
Doxorubicin—AURKA—lymph node—lung cancer	0.000101	0.00494	CbGeAlD
Doxorubicin—NOS3—lung—lung cancer	0.000101	0.00493	CbGeAlD
Doxorubicin—CBR1—lung—lung cancer	9.57e-05	0.00468	CbGeAlD
Doxorubicin—ABCC10—trachea—lung cancer	9.53e-05	0.00466	CbGeAlD
Doxorubicin—POR—bone marrow—lung cancer	9.52e-05	0.00465	CbGeAlD
Doxorubicin—AKR1C3—lung—lung cancer	9.45e-05	0.00462	CbGeAlD
Doxorubicin—NDUFS2—lymph node—lung cancer	9.01e-05	0.0044	CbGeAlD
Doxorubicin—ABCC10—cardiac atrium—lung cancer	8.95e-05	0.00437	CbGeAlD
Doxorubicin—NDUFS3—lymph node—lung cancer	8.9e-05	0.00435	CbGeAlD
Doxorubicin—TOP2A—bone marrow—lung cancer	8.88e-05	0.00434	CbGeAlD
Doxorubicin—POR—lung—lung cancer	8.63e-05	0.00422	CbGeAlD
Doxorubicin—DHCR7—lymph node—lung cancer	8.46e-05	0.00413	CbGeAlD
Doxorubicin—TOP2A—lung—lung cancer	8.04e-05	0.00393	CbGeAlD
Doxorubicin—ABCC6—Podofilox—Teniposide—lung cancer	8.03e-05	0.0737	CbGdCrCtD
Doxorubicin—YWHAG—lymph node—lung cancer	7.76e-05	0.00379	CbGeAlD
Doxorubicin—NQO1—lung—lung cancer	7.66e-05	0.00375	CbGeAlD
Doxorubicin—ABCC10—bone marrow—lung cancer	7.56e-05	0.00369	CbGeAlD
Doxorubicin—ABCC1—bronchus—lung cancer	7.5e-05	0.00367	CbGeAlD
Doxorubicin—AKR1C3—Podofilox—Teniposide—lung cancer	7.02e-05	0.0645	CbGdCrCtD
Doxorubicin—RALBP1—lymph node—lung cancer	7.01e-05	0.00343	CbGeAlD
Doxorubicin—CYP2B6—respiratory system—lung cancer	6.96e-05	0.0034	CbGeAlD
Doxorubicin—NOS3—lymph node—lung cancer	6.9e-05	0.00337	CbGeAlD
Doxorubicin—ABCC3—lung—lung cancer	6.88e-05	0.00336	CbGeAlD
Doxorubicin—ABCC10—lung—lung cancer	6.85e-05	0.00335	CbGeAlD
Doxorubicin—ABCC1—trachea—lung cancer	6.74e-05	0.00329	CbGeAlD
Doxorubicin—CBR1—lymph node—lung cancer	6.54e-05	0.0032	CbGeAlD
Doxorubicin—AKR1C3—lymph node—lung cancer	6.46e-05	0.00316	CbGeAlD
Doxorubicin—ABCC1—cardiac atrium—lung cancer	6.33e-05	0.00309	CbGeAlD
Doxorubicin—AURKA—Irinotecan—Topotecan—lung cancer	6.05e-05	0.0556	CbGdCrCtD
Doxorubicin—POR—lymph node—lung cancer	5.9e-05	0.00288	CbGeAlD
Doxorubicin—CYP2B6—bronchus—lung cancer	5.73e-05	0.0028	CbGeAlD
Doxorubicin—NQO1—Vincristine—Vinorelbine—lung cancer	5.59e-05	0.0513	CbGdCrCtD
Doxorubicin—Daunorubicin—ABCB1—lung cancer	5.54e-05	0.189	CrCbGaD
Doxorubicin—TOP2A—lymph node—lung cancer	5.5e-05	0.00269	CbGeAlD
Doxorubicin—CYP1B1—lung—lung cancer	5.38e-05	0.00263	CbGeAlD
Doxorubicin—NQO1—lymph node—lung cancer	5.24e-05	0.00256	CbGeAlD
Doxorubicin—AURKA—Topotecan—Irinotecan—lung cancer	5.03e-05	0.0462	CbGdCrCtD
Doxorubicin—AURKA—Etoposide—Teniposide—lung cancer	4.99e-05	0.0459	CbGdCrCtD
Doxorubicin—ABCC1—lung—lung cancer	4.84e-05	0.00237	CbGeAlD
Doxorubicin—ABCC6—Podofilox—Etoposide—lung cancer	4.78e-05	0.0438	CbGdCrCtD
Doxorubicin—ABCC3—lymph node—lung cancer	4.7e-05	0.0023	CbGeAlD
Doxorubicin—ABCC10—lymph node—lung cancer	4.68e-05	0.00229	CbGeAlD
Doxorubicin—NQO1—Vincristine—Vinblastine—lung cancer	4.47e-05	0.041	CbGdCrCtD
Doxorubicin—AKR1C3—Vincristine—Vinorelbine—lung cancer	4.47e-05	0.041	CbGdCrCtD
Doxorubicin—ABCG2—bone marrow—lung cancer	4.42e-05	0.00216	CbGeAlD
Doxorubicin—CBR3—Teniposide—Etoposide—lung cancer	4.3e-05	0.0395	CbGdCrCtD
Doxorubicin—AKR1C3—Podofilox—Etoposide—lung cancer	4.17e-05	0.0383	CbGdCrCtD
Doxorubicin—ABCG2—lung—lung cancer	4.01e-05	0.00196	CbGeAlD
Doxorubicin—ABCC2—lymph node—lung cancer	3.76e-05	0.00184	CbGeAlD
Doxorubicin—ABCB1—respiratory system—lung cancer	3.72e-05	0.00182	CbGeAlD
Doxorubicin—CYP2B6—lung—lung cancer	3.7e-05	0.00181	CbGeAlD
Doxorubicin—CYP1B1—lymph node—lung cancer	3.68e-05	0.0018	CbGeAlD
Doxorubicin—AKR1C3—Vinblastine—Vinorelbine—lung cancer	3.59e-05	0.033	CbGdCrCtD
Doxorubicin—AURKA—Methotrexate—Pemetrexed—lung cancer	3.58e-05	0.0329	CbGdCrCtD
Doxorubicin—AKR1C3—Vincristine—Vinblastine—lung cancer	3.57e-05	0.0328	CbGdCrCtD
Doxorubicin—CBR1—Vincristine—Vinorelbine—lung cancer	3.41e-05	0.0313	CbGdCrCtD
Doxorubicin—ABCC1—lymph node—lung cancer	3.31e-05	0.00162	CbGeAlD
Doxorubicin—ABCB1—epithelium—lung cancer	3.11e-05	0.00152	CbGeAlD
Doxorubicin—ABCB1—trachea—lung cancer	2.75e-05	0.00134	CbGeAlD
Doxorubicin—ABCG2—lymph node—lung cancer	2.74e-05	0.00134	CbGeAlD
Doxorubicin—CBR1—Vincristine—Vinblastine—lung cancer	2.73e-05	0.025	CbGdCrCtD
Doxorubicin—TOP2A—Docetaxel—Paclitaxel—lung cancer	2.7e-05	0.0248	CbGdCrCtD
Doxorubicin—TOP2A—Irinotecan—Topotecan—lung cancer	2.31e-05	0.0212	CbGdCrCtD
Doxorubicin—AURKA—Teniposide—Etoposide—lung cancer	2.27e-05	0.0208	CbGdCrCtD
Doxorubicin—ABCB1—bone marrow—lung cancer	2.18e-05	0.00107	CbGeAlD
Doxorubicin—TOP2A—Erlotinib—Gefitinib—lung cancer	2.02e-05	0.0185	CbGdCrCtD
Doxorubicin—ABCB1—lung—lung cancer	1.98e-05	0.000966	CbGeAlD
Doxorubicin—TOP2A—Topotecan—Irinotecan—lung cancer	1.92e-05	0.0176	CbGdCrCtD
Doxorubicin—TOP2A—Etoposide—Teniposide—lung cancer	1.91e-05	0.0175	CbGdCrCtD
Doxorubicin—CBR3—Azacitidine—Gemcitabine—lung cancer	1.73e-05	0.0159	CbGdCrCtD
Doxorubicin—TOP2A—Vindesine—Vinorelbine—lung cancer	1.72e-05	0.0158	CbGdCrCtD
Doxorubicin—TOP2A—Podofilox—Teniposide—lung cancer	1.46e-05	0.0134	CbGdCrCtD
Doxorubicin—TOP2A—Vindesine—Vinblastine—lung cancer	1.37e-05	0.0126	CbGdCrCtD
Doxorubicin—TOP2A—Methotrexate—Pemetrexed—lung cancer	1.37e-05	0.0126	CbGdCrCtD
Doxorubicin—ABCB1—lymph node—lung cancer	1.35e-05	0.000661	CbGeAlD
Doxorubicin—TOP2A—Paclitaxel—Docetaxel—lung cancer	1.35e-05	0.0124	CbGdCrCtD
Doxorubicin—TOP2A—Afatinib—Gefitinib—lung cancer	1.32e-05	0.0121	CbGdCrCtD
Doxorubicin—TOP2A—Gefitinib—Erlotinib—lung cancer	1.29e-05	0.0119	CbGdCrCtD
Doxorubicin—CBR1—Azacitidine—Gemcitabine—lung cancer	1.28e-05	0.0118	CbGdCrCtD
Doxorubicin—AURKA—Cytarabine—Gemcitabine—lung cancer	1.27e-05	0.0117	CbGdCrCtD
Doxorubicin—TOP2A—Vincristine—Vinorelbine—lung cancer	9.26e-06	0.00851	CbGdCrCtD
Doxorubicin—TOP2A—Vinorelbine—Vinblastine—lung cancer	8.66e-06	0.00795	CbGdCrCtD
Doxorubicin—TOP2A—Teniposide—Etoposide—lung cancer	8.65e-06	0.00795	CbGdCrCtD
Doxorubicin—TOP2A—Podofilox—Etoposide—lung cancer	8.65e-06	0.00795	CbGdCrCtD
Doxorubicin—Diarrhoea—Vinorelbine—lung cancer	7.88e-06	0.000153	CcSEcCtD
Doxorubicin—Dysgeusia—Docetaxel—lung cancer	7.88e-06	0.000153	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Cisplatin—lung cancer	7.86e-06	0.000153	CcSEcCtD
Doxorubicin—Infection—Etoposide—lung cancer	7.85e-06	0.000153	CcSEcCtD
Doxorubicin—Feeling abnormal—Irinotecan—lung cancer	7.83e-06	0.000152	CcSEcCtD
Doxorubicin—Confusional state—Paclitaxel—lung cancer	7.81e-06	0.000152	CcSEcCtD
Doxorubicin—Back pain—Docetaxel—lung cancer	7.78e-06	0.000151	CcSEcCtD
Doxorubicin—Dysuria—Methotrexate—lung cancer	7.78e-06	0.000151	CcSEcCtD
Doxorubicin—Neutropenia—Methotrexate—lung cancer	7.78e-06	0.000151	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Irinotecan—lung cancer	7.77e-06	0.000151	CcSEcCtD
Doxorubicin—Oedema—Paclitaxel—lung cancer	7.75e-06	0.000151	CcSEcCtD
Doxorubicin—Anaphylactic shock—Paclitaxel—lung cancer	7.75e-06	0.000151	CcSEcCtD
Doxorubicin—Paraesthesia—Cisplatin—lung cancer	7.74e-06	0.000151	CcSEcCtD
Doxorubicin—Thrombocytopenia—Etoposide—lung cancer	7.74e-06	0.000151	CcSEcCtD
Doxorubicin—Muscle spasms—Docetaxel—lung cancer	7.73e-06	0.000151	CcSEcCtD
Doxorubicin—Upper respiratory tract infection—Methotrexate—lung cancer	7.73e-06	0.000151	CcSEcCtD
Doxorubicin—Tachycardia—Etoposide—lung cancer	7.71e-06	0.00015	CcSEcCtD
Doxorubicin—Infection—Paclitaxel—lung cancer	7.7e-06	0.00015	CcSEcCtD
Doxorubicin—Dyspnoea—Cisplatin—lung cancer	7.69e-06	0.00015	CcSEcCtD
Doxorubicin—Skin disorder—Etoposide—lung cancer	7.67e-06	0.000149	CcSEcCtD
Doxorubicin—Hyperhidrosis—Etoposide—lung cancer	7.64e-06	0.000149	CcSEcCtD
Doxorubicin—Feeling abnormal—Gemcitabine—lung cancer	7.62e-06	0.000148	CcSEcCtD
Doxorubicin—Shock—Paclitaxel—lung cancer	7.62e-06	0.000148	CcSEcCtD
Doxorubicin—Dizziness—Vinorelbine—lung cancer	7.62e-06	0.000148	CcSEcCtD
Doxorubicin—Nervous system disorder—Paclitaxel—lung cancer	7.6e-06	0.000148	CcSEcCtD
Doxorubicin—Photosensitivity reaction—Methotrexate—lung cancer	7.6e-06	0.000148	CcSEcCtD
Doxorubicin—Thrombocytopenia—Paclitaxel—lung cancer	7.58e-06	0.000148	CcSEcCtD
Doxorubicin—Tachycardia—Paclitaxel—lung cancer	7.56e-06	0.000147	CcSEcCtD
Doxorubicin—Anorexia—Etoposide—lung cancer	7.53e-06	0.000147	CcSEcCtD
Doxorubicin—Skin disorder—Paclitaxel—lung cancer	7.52e-06	0.000146	CcSEcCtD
Doxorubicin—Abdominal pain—Irinotecan—lung cancer	7.51e-06	0.000146	CcSEcCtD
Doxorubicin—Body temperature increased—Irinotecan—lung cancer	7.51e-06	0.000146	CcSEcCtD
Doxorubicin—Decreased appetite—Cisplatin—lung cancer	7.5e-06	0.000146	CcSEcCtD
Doxorubicin—Hyperhidrosis—Paclitaxel—lung cancer	7.49e-06	0.000146	CcSEcCtD
Doxorubicin—Pneumonia—Methotrexate—lung cancer	7.46e-06	0.000145	CcSEcCtD
Doxorubicin—TOP2A—Vinblastine—Vinorelbine—lung cancer	7.45e-06	0.00684	CbGdCrCtD
Doxorubicin—Gastrointestinal disorder—Cisplatin—lung cancer	7.45e-06	0.000145	CcSEcCtD
Doxorubicin—Anaemia—Docetaxel—lung cancer	7.44e-06	0.000145	CcSEcCtD
Doxorubicin—Infestation NOS—Methotrexate—lung cancer	7.42e-06	0.000144	CcSEcCtD
Doxorubicin—Infestation—Methotrexate—lung cancer	7.42e-06	0.000144	CcSEcCtD
Doxorubicin—Drowsiness—Methotrexate—lung cancer	7.42e-06	0.000144	CcSEcCtD
Doxorubicin—TOP2A—Vincristine—Vinblastine—lung cancer	7.41e-06	0.0068	CbGdCrCtD
Doxorubicin—Anorexia—Paclitaxel—lung cancer	7.38e-06	0.000144	CcSEcCtD
Doxorubicin—Hypotension—Etoposide—lung cancer	7.38e-06	0.000144	CcSEcCtD
Doxorubicin—Pain—Cisplatin—lung cancer	7.37e-06	0.000144	CcSEcCtD
Doxorubicin—Stevens-Johnson syndrome—Methotrexate—lung cancer	7.36e-06	0.000143	CcSEcCtD
Doxorubicin—Vomiting—Vinorelbine—lung cancer	7.32e-06	0.000143	CcSEcCtD
Doxorubicin—Body temperature increased—Gemcitabine—lung cancer	7.31e-06	0.000142	CcSEcCtD
Doxorubicin—Renal failure—Methotrexate—lung cancer	7.29e-06	0.000142	CcSEcCtD
Doxorubicin—Rash—Vinorelbine—lung cancer	7.26e-06	0.000141	CcSEcCtD
Doxorubicin—Dermatitis—Vinorelbine—lung cancer	7.25e-06	0.000141	CcSEcCtD
Doxorubicin—Hypotension—Paclitaxel—lung cancer	7.24e-06	0.000141	CcSEcCtD
Doxorubicin—Stomatitis—Methotrexate—lung cancer	7.23e-06	0.000141	CcSEcCtD
Doxorubicin—Headache—Vinorelbine—lung cancer	7.21e-06	0.00014	CcSEcCtD
Doxorubicin—Syncope—Docetaxel—lung cancer	7.21e-06	0.00014	CcSEcCtD
Doxorubicin—Conjunctivitis—Methotrexate—lung cancer	7.21e-06	0.00014	CcSEcCtD
Doxorubicin—Leukopenia—Docetaxel—lung cancer	7.2e-06	0.00014	CcSEcCtD
Doxorubicin—Sweating—Methotrexate—lung cancer	7.11e-06	0.000138	CcSEcCtD
Doxorubicin—Palpitations—Docetaxel—lung cancer	7.11e-06	0.000138	CcSEcCtD
Doxorubicin—Feeling abnormal—Cisplatin—lung cancer	7.11e-06	0.000138	CcSEcCtD
Doxorubicin—Paraesthesia—Etoposide—lung cancer	7.09e-06	0.000138	CcSEcCtD
Doxorubicin—Haematuria—Methotrexate—lung cancer	7.07e-06	0.000138	CcSEcCtD
Doxorubicin—Loss of consciousness—Docetaxel—lung cancer	7.07e-06	0.000138	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Paclitaxel—lung cancer	7.06e-06	0.000137	CcSEcCtD
Doxorubicin—Dyspnoea—Etoposide—lung cancer	7.04e-06	0.000137	CcSEcCtD
Doxorubicin—Somnolence—Etoposide—lung cancer	7.02e-06	0.000137	CcSEcCtD
Doxorubicin—Cough—Docetaxel—lung cancer	7.02e-06	0.000137	CcSEcCtD
Doxorubicin—Hepatobiliary disease—Methotrexate—lung cancer	7.02e-06	0.000137	CcSEcCtD
Doxorubicin—Insomnia—Paclitaxel—lung cancer	7.01e-06	0.000136	CcSEcCtD
Doxorubicin—Epistaxis—Methotrexate—lung cancer	7e-06	0.000136	CcSEcCtD
Doxorubicin—Hypersensitivity—Irinotecan—lung cancer	7e-06	0.000136	CcSEcCtD
Doxorubicin—Convulsion—Docetaxel—lung cancer	6.97e-06	0.000136	CcSEcCtD
Doxorubicin—Paraesthesia—Paclitaxel—lung cancer	6.96e-06	0.000135	CcSEcCtD
Doxorubicin—Hypertension—Docetaxel—lung cancer	6.95e-06	0.000135	CcSEcCtD
Doxorubicin—Agranulocytosis—Methotrexate—lung cancer	6.92e-06	0.000135	CcSEcCtD
Doxorubicin—Dyspnoea—Paclitaxel—lung cancer	6.91e-06	0.000134	CcSEcCtD
Doxorubicin—Somnolence—Paclitaxel—lung cancer	6.89e-06	0.000134	CcSEcCtD
Doxorubicin—Decreased appetite—Etoposide—lung cancer	6.87e-06	0.000134	CcSEcCtD
Doxorubicin—Arthralgia—Docetaxel—lung cancer	6.85e-06	0.000133	CcSEcCtD
Doxorubicin—Myalgia—Docetaxel—lung cancer	6.85e-06	0.000133	CcSEcCtD
Doxorubicin—Chest pain—Docetaxel—lung cancer	6.85e-06	0.000133	CcSEcCtD
Doxorubicin—Nausea—Vinorelbine—lung cancer	6.84e-06	0.000133	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Etoposide—lung cancer	6.82e-06	0.000133	CcSEcCtD
Doxorubicin—Dyspepsia—Paclitaxel—lung cancer	6.82e-06	0.000133	CcSEcCtD
Doxorubicin—Body temperature increased—Cisplatin—lung cancer	6.82e-06	0.000133	CcSEcCtD
Doxorubicin—Asthenia—Irinotecan—lung cancer	6.81e-06	0.000133	CcSEcCtD
Doxorubicin—Fatigue—Etoposide—lung cancer	6.81e-06	0.000133	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	6.8e-06	0.000132	CcSEcCtD
Doxorubicin—Pain—Etoposide—lung cancer	6.76e-06	0.000132	CcSEcCtD
Doxorubicin—Constipation—Etoposide—lung cancer	6.76e-06	0.000132	CcSEcCtD
Doxorubicin—Decreased appetite—Paclitaxel—lung cancer	6.73e-06	0.000131	CcSEcCtD
Doxorubicin—Dry mouth—Docetaxel—lung cancer	6.7e-06	0.00013	CcSEcCtD
Doxorubicin—Haemoglobin—Methotrexate—lung cancer	6.69e-06	0.00013	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Paclitaxel—lung cancer	6.69e-06	0.00013	CcSEcCtD
Doxorubicin—Fatigue—Paclitaxel—lung cancer	6.68e-06	0.00013	CcSEcCtD
Doxorubicin—Haemorrhage—Methotrexate—lung cancer	6.66e-06	0.00013	CcSEcCtD
Doxorubicin—Hepatitis—Methotrexate—lung cancer	6.66e-06	0.00013	CcSEcCtD
Doxorubicin—Asthenia—Gemcitabine—lung cancer	6.64e-06	0.000129	CcSEcCtD
Doxorubicin—Constipation—Paclitaxel—lung cancer	6.62e-06	0.000129	CcSEcCtD
Doxorubicin—Pain—Paclitaxel—lung cancer	6.62e-06	0.000129	CcSEcCtD
Doxorubicin—Confusional state—Docetaxel—lung cancer	6.62e-06	0.000129	CcSEcCtD
Doxorubicin—Pharyngitis—Methotrexate—lung cancer	6.61e-06	0.000129	CcSEcCtD
Doxorubicin—Urinary tract disorder—Methotrexate—lung cancer	6.58e-06	0.000128	CcSEcCtD
Doxorubicin—Anaphylactic shock—Docetaxel—lung cancer	6.57e-06	0.000128	CcSEcCtD
Doxorubicin—Oedema—Docetaxel—lung cancer	6.57e-06	0.000128	CcSEcCtD
Doxorubicin—Pruritus—Gemcitabine—lung cancer	6.55e-06	0.000127	CcSEcCtD
Doxorubicin—Urethral disorder—Methotrexate—lung cancer	6.53e-06	0.000127	CcSEcCtD
Doxorubicin—Infection—Docetaxel—lung cancer	6.52e-06	0.000127	CcSEcCtD
Doxorubicin—Feeling abnormal—Etoposide—lung cancer	6.51e-06	0.000127	CcSEcCtD
Doxorubicin—Diarrhoea—Irinotecan—lung cancer	6.5e-06	0.000127	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Etoposide—lung cancer	6.46e-06	0.000126	CcSEcCtD
Doxorubicin—Shock—Docetaxel—lung cancer	6.46e-06	0.000126	CcSEcCtD
Doxorubicin—Nervous system disorder—Docetaxel—lung cancer	6.44e-06	0.000125	CcSEcCtD
Doxorubicin—Thrombocytopenia—Docetaxel—lung cancer	6.43e-06	0.000125	CcSEcCtD
Doxorubicin—Visual impairment—Methotrexate—lung cancer	6.42e-06	0.000125	CcSEcCtD
Doxorubicin—Tachycardia—Docetaxel—lung cancer	6.41e-06	0.000125	CcSEcCtD
Doxorubicin—Feeling abnormal—Paclitaxel—lung cancer	6.38e-06	0.000124	CcSEcCtD
Doxorubicin—Skin disorder—Docetaxel—lung cancer	6.38e-06	0.000124	CcSEcCtD
Doxorubicin—Hypersensitivity—Cisplatin—lung cancer	6.35e-06	0.000124	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Paclitaxel—lung cancer	6.33e-06	0.000123	CcSEcCtD
Doxorubicin—Diarrhoea—Gemcitabine—lung cancer	6.33e-06	0.000123	CcSEcCtD
Doxorubicin—Erythema multiforme—Methotrexate—lung cancer	6.3e-06	0.000123	CcSEcCtD
Doxorubicin—Dizziness—Irinotecan—lung cancer	6.28e-06	0.000122	CcSEcCtD
Doxorubicin—Urticaria—Etoposide—lung cancer	6.28e-06	0.000122	CcSEcCtD
Doxorubicin—Anorexia—Docetaxel—lung cancer	6.26e-06	0.000122	CcSEcCtD
Doxorubicin—Body temperature increased—Etoposide—lung cancer	6.25e-06	0.000122	CcSEcCtD
Doxorubicin—Abdominal pain—Etoposide—lung cancer	6.25e-06	0.000122	CcSEcCtD
Doxorubicin—Eye disorder—Methotrexate—lung cancer	6.22e-06	0.000121	CcSEcCtD
Doxorubicin—Tinnitus—Methotrexate—lung cancer	6.21e-06	0.000121	CcSEcCtD
Doxorubicin—Asthenia—Cisplatin—lung cancer	6.19e-06	0.00012	CcSEcCtD
Doxorubicin—Cardiac disorder—Methotrexate—lung cancer	6.18e-06	0.00012	CcSEcCtD
Doxorubicin—Urticaria—Paclitaxel—lung cancer	6.15e-06	0.00012	CcSEcCtD
Doxorubicin—Hypotension—Docetaxel—lung cancer	6.14e-06	0.000119	CcSEcCtD
Doxorubicin—Body temperature increased—Paclitaxel—lung cancer	6.12e-06	0.000119	CcSEcCtD
Doxorubicin—Abdominal pain—Paclitaxel—lung cancer	6.12e-06	0.000119	CcSEcCtD
Doxorubicin—Angiopathy—Methotrexate—lung cancer	6.04e-06	0.000118	CcSEcCtD
Doxorubicin—Vomiting—Irinotecan—lung cancer	6.04e-06	0.000118	CcSEcCtD
Doxorubicin—Immune system disorder—Methotrexate—lung cancer	6.02e-06	0.000117	CcSEcCtD
Doxorubicin—Mediastinal disorder—Methotrexate—lung cancer	6e-06	0.000117	CcSEcCtD
Doxorubicin—Rash—Irinotecan—lung cancer	5.99e-06	0.000117	CcSEcCtD
Doxorubicin—Dermatitis—Irinotecan—lung cancer	5.98e-06	0.000116	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Docetaxel—lung cancer	5.98e-06	0.000116	CcSEcCtD
Doxorubicin—Chills—Methotrexate—lung cancer	5.98e-06	0.000116	CcSEcCtD
Doxorubicin—Headache—Irinotecan—lung cancer	5.95e-06	0.000116	CcSEcCtD
Doxorubicin—Insomnia—Docetaxel—lung cancer	5.94e-06	0.000116	CcSEcCtD
Doxorubicin—Diarrhoea—Cisplatin—lung cancer	5.9e-06	0.000115	CcSEcCtD
Doxorubicin—Paraesthesia—Docetaxel—lung cancer	5.9e-06	0.000115	CcSEcCtD
Doxorubicin—Alopecia—Methotrexate—lung cancer	5.89e-06	0.000115	CcSEcCtD
Doxorubicin—Vomiting—Gemcitabine—lung cancer	5.88e-06	0.000115	CcSEcCtD
Doxorubicin—Dyspnoea—Docetaxel—lung cancer	5.85e-06	0.000114	CcSEcCtD
Doxorubicin—Somnolence—Docetaxel—lung cancer	5.84e-06	0.000114	CcSEcCtD
Doxorubicin—Mental disorder—Methotrexate—lung cancer	5.84e-06	0.000114	CcSEcCtD
Doxorubicin—Rash—Gemcitabine—lung cancer	5.83e-06	0.000114	CcSEcCtD
Doxorubicin—Dermatitis—Gemcitabine—lung cancer	5.83e-06	0.000113	CcSEcCtD
Doxorubicin—Hypersensitivity—Etoposide—lung cancer	5.82e-06	0.000113	CcSEcCtD
Doxorubicin—Erythema—Methotrexate—lung cancer	5.8e-06	0.000113	CcSEcCtD
Doxorubicin—Malnutrition—Methotrexate—lung cancer	5.8e-06	0.000113	CcSEcCtD
Doxorubicin—Headache—Gemcitabine—lung cancer	5.8e-06	0.000113	CcSEcCtD
Doxorubicin—Dyspepsia—Docetaxel—lung cancer	5.78e-06	0.000113	CcSEcCtD
Doxorubicin—Decreased appetite—Docetaxel—lung cancer	5.71e-06	0.000111	CcSEcCtD
Doxorubicin—Hypersensitivity—Paclitaxel—lung cancer	5.71e-06	0.000111	CcSEcCtD
Doxorubicin—Dysgeusia—Methotrexate—lung cancer	5.68e-06	0.000111	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Docetaxel—lung cancer	5.67e-06	0.00011	CcSEcCtD
Doxorubicin—Asthenia—Etoposide—lung cancer	5.67e-06	0.00011	CcSEcCtD
Doxorubicin—Fatigue—Docetaxel—lung cancer	5.66e-06	0.00011	CcSEcCtD
Doxorubicin—Nausea—Irinotecan—lung cancer	5.64e-06	0.00011	CcSEcCtD
Doxorubicin—Pain—Docetaxel—lung cancer	5.61e-06	0.000109	CcSEcCtD
Doxorubicin—Constipation—Docetaxel—lung cancer	5.61e-06	0.000109	CcSEcCtD
Doxorubicin—Back pain—Methotrexate—lung cancer	5.61e-06	0.000109	CcSEcCtD
Doxorubicin—Pruritus—Etoposide—lung cancer	5.59e-06	0.000109	CcSEcCtD
Doxorubicin—Asthenia—Paclitaxel—lung cancer	5.56e-06	0.000108	CcSEcCtD
Doxorubicin—Nausea—Gemcitabine—lung cancer	5.5e-06	0.000107	CcSEcCtD
Doxorubicin—Vomiting—Cisplatin—lung cancer	5.48e-06	0.000107	CcSEcCtD
Doxorubicin—Pruritus—Paclitaxel—lung cancer	5.48e-06	0.000107	CcSEcCtD
Doxorubicin—Vision blurred—Methotrexate—lung cancer	5.46e-06	0.000106	CcSEcCtD
Doxorubicin—Rash—Cisplatin—lung cancer	5.44e-06	0.000106	CcSEcCtD
Doxorubicin—Dermatitis—Cisplatin—lung cancer	5.43e-06	0.000106	CcSEcCtD
Doxorubicin—Feeling abnormal—Docetaxel—lung cancer	5.41e-06	0.000105	CcSEcCtD
Doxorubicin—Diarrhoea—Etoposide—lung cancer	5.41e-06	0.000105	CcSEcCtD
Doxorubicin—Ill-defined disorder—Methotrexate—lung cancer	5.38e-06	0.000105	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Docetaxel—lung cancer	5.37e-06	0.000105	CcSEcCtD
Doxorubicin—Anaemia—Methotrexate—lung cancer	5.36e-06	0.000104	CcSEcCtD
Doxorubicin—Diarrhoea—Paclitaxel—lung cancer	5.3e-06	0.000103	CcSEcCtD
Doxorubicin—Malaise—Methotrexate—lung cancer	5.23e-06	0.000102	CcSEcCtD
Doxorubicin—Dizziness—Etoposide—lung cancer	5.22e-06	0.000102	CcSEcCtD
Doxorubicin—Vertigo—Methotrexate—lung cancer	5.21e-06	0.000101	CcSEcCtD
Doxorubicin—Body temperature increased—Docetaxel—lung cancer	5.19e-06	0.000101	CcSEcCtD
Doxorubicin—Abdominal pain—Docetaxel—lung cancer	5.19e-06	0.000101	CcSEcCtD
Doxorubicin—Leukopenia—Methotrexate—lung cancer	5.19e-06	0.000101	CcSEcCtD
Doxorubicin—Dizziness—Paclitaxel—lung cancer	5.12e-06	9.97e-05	CcSEcCtD
Doxorubicin—Nausea—Cisplatin—lung cancer	5.12e-06	9.97e-05	CcSEcCtD
Doxorubicin—Cough—Methotrexate—lung cancer	5.06e-06	9.85e-05	CcSEcCtD
Doxorubicin—Convulsion—Methotrexate—lung cancer	5.02e-06	9.78e-05	CcSEcCtD
Doxorubicin—Vomiting—Etoposide—lung cancer	5.02e-06	9.78e-05	CcSEcCtD
Doxorubicin—Rash—Etoposide—lung cancer	4.98e-06	9.7e-05	CcSEcCtD
Doxorubicin—Dermatitis—Etoposide—lung cancer	4.98e-06	9.69e-05	CcSEcCtD
Doxorubicin—Headache—Etoposide—lung cancer	4.95e-06	9.64e-05	CcSEcCtD
Doxorubicin—Chest pain—Methotrexate—lung cancer	4.94e-06	9.61e-05	CcSEcCtD
Doxorubicin—Myalgia—Methotrexate—lung cancer	4.94e-06	9.61e-05	CcSEcCtD
Doxorubicin—Arthralgia—Methotrexate—lung cancer	4.94e-06	9.61e-05	CcSEcCtD
Doxorubicin—Vomiting—Paclitaxel—lung cancer	4.93e-06	9.59e-05	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	4.9e-06	9.54e-05	CcSEcCtD
Doxorubicin—Rash—Paclitaxel—lung cancer	4.88e-06	9.51e-05	CcSEcCtD
Doxorubicin—Dermatitis—Paclitaxel—lung cancer	4.88e-06	9.5e-05	CcSEcCtD
Doxorubicin—Discomfort—Methotrexate—lung cancer	4.88e-06	9.49e-05	CcSEcCtD
Doxorubicin—TOP2A—Cytarabine—Gemcitabine—lung cancer	4.87e-06	0.00447	CbGdCrCtD
Doxorubicin—Headache—Paclitaxel—lung cancer	4.85e-06	9.45e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Docetaxel—lung cancer	4.84e-06	9.42e-05	CcSEcCtD
Doxorubicin—Confusional state—Methotrexate—lung cancer	4.77e-06	9.29e-05	CcSEcCtD
Doxorubicin—Anaphylactic shock—Methotrexate—lung cancer	4.73e-06	9.21e-05	CcSEcCtD
Doxorubicin—Asthenia—Docetaxel—lung cancer	4.71e-06	9.17e-05	CcSEcCtD
Doxorubicin—Infection—Methotrexate—lung cancer	4.7e-06	9.15e-05	CcSEcCtD
Doxorubicin—Nausea—Etoposide—lung cancer	4.69e-06	9.14e-05	CcSEcCtD
Doxorubicin—Pruritus—Docetaxel—lung cancer	4.65e-06	9.04e-05	CcSEcCtD
Doxorubicin—Nervous system disorder—Methotrexate—lung cancer	4.64e-06	9.03e-05	CcSEcCtD
Doxorubicin—Thrombocytopenia—Methotrexate—lung cancer	4.63e-06	9.02e-05	CcSEcCtD
Doxorubicin—Nausea—Paclitaxel—lung cancer	4.6e-06	8.96e-05	CcSEcCtD
Doxorubicin—Skin disorder—Methotrexate—lung cancer	4.6e-06	8.95e-05	CcSEcCtD
Doxorubicin—Hyperhidrosis—Methotrexate—lung cancer	4.57e-06	8.91e-05	CcSEcCtD
Doxorubicin—Anorexia—Methotrexate—lung cancer	4.51e-06	8.78e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Docetaxel—lung cancer	4.49e-06	8.75e-05	CcSEcCtD
Doxorubicin—Hypotension—Methotrexate—lung cancer	4.42e-06	8.61e-05	CcSEcCtD
Doxorubicin—Dizziness—Docetaxel—lung cancer	4.34e-06	8.45e-05	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Methotrexate—lung cancer	4.31e-06	8.39e-05	CcSEcCtD
Doxorubicin—Insomnia—Methotrexate—lung cancer	4.28e-06	8.33e-05	CcSEcCtD
Doxorubicin—Paraesthesia—Methotrexate—lung cancer	4.25e-06	8.27e-05	CcSEcCtD
Doxorubicin—Dyspnoea—Methotrexate—lung cancer	4.22e-06	8.21e-05	CcSEcCtD
Doxorubicin—Somnolence—Methotrexate—lung cancer	4.21e-06	8.19e-05	CcSEcCtD
Doxorubicin—Vomiting—Docetaxel—lung cancer	4.17e-06	8.13e-05	CcSEcCtD
Doxorubicin—Dyspepsia—Methotrexate—lung cancer	4.17e-06	8.11e-05	CcSEcCtD
Doxorubicin—Rash—Docetaxel—lung cancer	4.14e-06	8.06e-05	CcSEcCtD
Doxorubicin—Dermatitis—Docetaxel—lung cancer	4.14e-06	8.05e-05	CcSEcCtD
Doxorubicin—Decreased appetite—Methotrexate—lung cancer	4.11e-06	8.01e-05	CcSEcCtD
Doxorubicin—Headache—Docetaxel—lung cancer	4.11e-06	8.01e-05	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Methotrexate—lung cancer	4.09e-06	7.95e-05	CcSEcCtD
Doxorubicin—Fatigue—Methotrexate—lung cancer	4.08e-06	7.94e-05	CcSEcCtD
Doxorubicin—Pain—Methotrexate—lung cancer	4.05e-06	7.88e-05	CcSEcCtD
Doxorubicin—Nausea—Docetaxel—lung cancer	3.9e-06	7.59e-05	CcSEcCtD
Doxorubicin—Feeling abnormal—Methotrexate—lung cancer	3.9e-06	7.59e-05	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Methotrexate—lung cancer	3.87e-06	7.53e-05	CcSEcCtD
Doxorubicin—Urticaria—Methotrexate—lung cancer	3.76e-06	7.32e-05	CcSEcCtD
Doxorubicin—Abdominal pain—Methotrexate—lung cancer	3.74e-06	7.28e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Methotrexate—lung cancer	3.74e-06	7.28e-05	CcSEcCtD
Doxorubicin—TOP2A—Azacitidine—Gemcitabine—lung cancer	3.49e-06	0.0032	CbGdCrCtD
Doxorubicin—Hypersensitivity—Methotrexate—lung cancer	3.49e-06	6.79e-05	CcSEcCtD
Doxorubicin—Asthenia—Methotrexate—lung cancer	3.4e-06	6.61e-05	CcSEcCtD
Doxorubicin—Pruritus—Methotrexate—lung cancer	3.35e-06	6.52e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Methotrexate—lung cancer	3.24e-06	6.3e-05	CcSEcCtD
Doxorubicin—Dizziness—Methotrexate—lung cancer	3.13e-06	6.09e-05	CcSEcCtD
Doxorubicin—Vomiting—Methotrexate—lung cancer	3.01e-06	5.86e-05	CcSEcCtD
Doxorubicin—Rash—Methotrexate—lung cancer	2.98e-06	5.81e-05	CcSEcCtD
Doxorubicin—Dermatitis—Methotrexate—lung cancer	2.98e-06	5.8e-05	CcSEcCtD
Doxorubicin—Headache—Methotrexate—lung cancer	2.96e-06	5.77e-05	CcSEcCtD
Doxorubicin—Nausea—Methotrexate—lung cancer	2.81e-06	5.47e-05	CcSEcCtD
Doxorubicin—ABCB1—Metabolism—ENO2—lung cancer	5.83e-07	1.53e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HPGDS—lung cancer	5.83e-07	1.53e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—EP300—lung cancer	5.83e-07	1.53e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SDC4—lung cancer	5.8e-07	1.52e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPP2R1B—lung cancer	5.79e-07	1.52e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EP300—lung cancer	5.76e-07	1.51e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NCOA3—lung cancer	5.76e-07	1.51e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—STK11—lung cancer	5.74e-07	1.51e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PIK3CB—lung cancer	5.73e-07	1.5e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.7e-07	1.5e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—lung cancer	5.68e-07	1.49e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCL8—lung cancer	5.68e-07	1.49e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTT1—lung cancer	5.65e-07	1.48e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HRAS—lung cancer	5.63e-07	1.48e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CG—lung cancer	5.62e-07	1.47e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SRC—lung cancer	5.61e-07	1.47e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCG2—lung cancer	5.6e-07	1.47e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ADCY1—lung cancer	5.6e-07	1.47e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—KRAS—lung cancer	5.6e-07	1.47e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GCLC—lung cancer	5.59e-07	1.47e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP2A6—lung cancer	5.59e-07	1.47e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PIK3CB—lung cancer	5.5e-07	1.44e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HPGDS—lung cancer	5.49e-07	1.44e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ENO2—lung cancer	5.49e-07	1.44e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	5.49e-07	1.44e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VEGFA—lung cancer	5.46e-07	1.43e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPP2R1B—lung cancer	5.46e-07	1.43e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—lung cancer	5.45e-07	1.43e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CG—lung cancer	5.44e-07	1.43e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CASP3—lung cancer	5.44e-07	1.43e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2—lung cancer	5.43e-07	1.42e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—APOA1—lung cancer	5.42e-07	1.42e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—AKT1—lung cancer	5.41e-07	1.42e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—STAT3—lung cancer	5.41e-07	1.42e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NRAS—lung cancer	5.39e-07	1.41e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6—lung cancer	5.39e-07	1.41e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—POMC—lung cancer	5.35e-07	1.4e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTT1—lung cancer	5.33e-07	1.4e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTP1—lung cancer	5.31e-07	1.39e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ENO1—lung cancer	5.3e-07	1.39e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	5.29e-07	1.39e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCND1—lung cancer	5.29e-07	1.39e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MDM2—lung cancer	5.29e-07	1.39e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PIK3CA—lung cancer	5.29e-07	1.39e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—RRM1—lung cancer	5.28e-07	1.39e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTA3—lung cancer	5.28e-07	1.39e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—JUN—lung cancer	5.28e-07	1.38e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—RAF1—lung cancer	5.27e-07	1.38e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GCLC—lung cancer	5.27e-07	1.38e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP2A6—lung cancer	5.27e-07	1.38e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CREBBP—lung cancer	5.21e-07	1.37e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ERBB2—lung cancer	5.21e-07	1.37e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—POMC—lung cancer	5.18e-07	1.36e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CAT—lung cancer	5.17e-07	1.36e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MAPK3—lung cancer	5.16e-07	1.35e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PIK3CA—lung cancer	5.15e-07	1.35e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PIK3CB—lung cancer	5.14e-07	1.35e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MTOR—lung cancer	5.14e-07	1.35e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MMP9—lung cancer	5.14e-07	1.35e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD4—lung cancer	5.13e-07	1.35e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CDKN1A—lung cancer	5.12e-07	1.34e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTEN—lung cancer	5.11e-07	1.34e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PIK3CA—lung cancer	5.1e-07	1.34e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—lung cancer	5.1e-07	1.34e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CREBBP—lung cancer	5.04e-07	1.32e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ABCB1—lung cancer	5.03e-07	1.32e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MYC—lung cancer	5.02e-07	1.32e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ENO1—lung cancer	4.99e-07	1.31e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—AKT1—lung cancer	4.97e-07	1.3e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—B4GALT5—lung cancer	4.97e-07	1.3e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	4.96e-07	1.3e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTEN—lung cancer	4.95e-07	1.3e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CG—lung cancer	4.95e-07	1.3e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CD—lung cancer	4.94e-07	1.3e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—TYMS—lung cancer	4.94e-07	1.3e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EGFR—lung cancer	4.91e-07	1.29e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTM1—lung cancer	4.88e-07	1.28e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALB—lung cancer	4.88e-07	1.28e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EP300—lung cancer	4.87e-07	1.28e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTA4—lung cancer	4.83e-07	1.27e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CD—lung cancer	4.78e-07	1.25e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HRAS—lung cancer	4.76e-07	1.25e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP2E1—lung cancer	4.75e-07	1.25e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTEN—lung cancer	4.75e-07	1.25e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PIK3CA—lung cancer	4.74e-07	1.24e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SRC—lung cancer	4.74e-07	1.24e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—EP300—lung cancer	4.73e-07	1.24e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALB—lung cancer	4.72e-07	1.24e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTA2—lung cancer	4.71e-07	1.24e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—POMC—lung cancer	4.71e-07	1.23e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NQO1—lung cancer	4.7e-07	1.23e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—KRAS—lung cancer	4.64e-07	1.22e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP1A1—lung cancer	4.63e-07	1.21e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VEGFA—lung cancer	4.61e-07	1.21e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ERCC2—lung cancer	4.59e-07	1.2e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CREBBP—lung cancer	4.59e-07	1.2e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—STAT3—lung cancer	4.57e-07	1.2e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NRAS—lung cancer	4.56e-07	1.2e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—lung cancer	4.56e-07	1.19e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTA1—lung cancer	4.54e-07	1.19e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—EP300—lung cancer	4.53e-07	1.19e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCC3—lung cancer	4.49e-07	1.18e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	4.48e-07	1.18e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP2E1—lung cancer	4.48e-07	1.17e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CDKN1A—lung cancer	4.45e-07	1.17e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTEN—lung cancer	4.44e-07	1.17e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NQO1—lung cancer	4.43e-07	1.16e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAPK3—lung cancer	4.36e-07	1.14e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AKR1C1—lung cancer	4.35e-07	1.14e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CD—lung cancer	4.35e-07	1.14e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AKT1—lung cancer	4.32e-07	1.13e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PIK3CA—lung cancer	4.31e-07	1.13e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CB—lung cancer	4.31e-07	1.13e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALB—lung cancer	4.29e-07	1.13e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—lung cancer	4.27e-07	1.12e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PIK3CA—lung cancer	4.26e-07	1.12e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MYC—lung cancer	4.24e-07	1.11e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EP300—lung cancer	4.24e-07	1.11e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—STK11—lung cancer	4.24e-07	1.11e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—UGT1A1—lung cancer	4.22e-07	1.11e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—AKT1—lung cancer	4.2e-07	1.1e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AKT1—lung cancer	4.17e-07	1.09e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CB—lung cancer	4.17e-07	1.09e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EGFR—lung cancer	4.15e-07	1.09e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—lung cancer	4.13e-07	1.08e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—lung cancer	4.13e-07	1.08e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SRC—lung cancer	4.12e-07	1.08e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GNG11—lung cancer	4.07e-07	1.07e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—STK11—lung cancer	3.99e-07	1.05e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—STAT3—lung cancer	3.97e-07	1.04e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOA1—lung cancer	3.97e-07	1.04e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NRAS—lung cancer	3.97e-07	1.04e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HRAS—lung cancer	3.95e-07	1.03e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KRAS—lung cancer	3.92e-07	1.03e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTP1—lung cancer	3.92e-07	1.03e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALDOA—lung cancer	3.88e-07	1.02e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AKT1—lung cancer	3.87e-07	1.02e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CAT—lung cancer	3.81e-07	1e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MAPK3—lung cancer	3.8e-07	9.96e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CB—lung cancer	3.79e-07	9.94e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—lung cancer	3.78e-07	9.9e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NCOA3—lung cancer	3.76e-07	9.87e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—lung cancer	3.76e-07	9.85e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTEN—lung cancer	3.72e-07	9.76e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MYC—lung cancer	3.69e-07	9.69e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTP1—lung cancer	3.69e-07	9.69e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ADCY1—lung cancer	3.66e-07	9.61e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCG2—lung cancer	3.66e-07	9.61e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TYMS—lung cancer	3.64e-07	9.56e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CG—lung cancer	3.63e-07	9.51e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EGFR—lung cancer	3.61e-07	9.47e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PIK3CA—lung cancer	3.6e-07	9.45e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTM1—lung cancer	3.6e-07	9.45e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTEN—lung cancer	3.6e-07	9.44e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CAT—lung cancer	3.59e-07	9.43e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HPGDS—lung cancer	3.59e-07	9.42e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ENO2—lung cancer	3.59e-07	9.42e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.57e-07	9.36e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—EP300—lung cancer	3.55e-07	9.31e-06	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AKT1—lung cancer	3.52e-07	9.23e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCB1—lung cancer	3.5e-07	9.17e-06	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PIK3CA—lung cancer	3.5e-07	9.17e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—lung cancer	3.49e-07	9.14e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTT1—lung cancer	3.48e-07	9.14e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AKT1—lung cancer	3.48e-07	9.14e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—POMC—lung cancer	3.45e-07	9.05e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP2A6—lung cancer	3.44e-07	9.03e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GCLC—lung cancer	3.44e-07	9.03e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TYMS—lung cancer	3.43e-07	9e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—EP300—lung cancer	3.43e-07	9e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP1A1—lung cancer	3.41e-07	8.95e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—KRAS—lung cancer	3.41e-07	8.95e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTM1—lung cancer	3.39e-07	8.9e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ERCC2—lung cancer	3.39e-07	8.88e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CREBBP—lung cancer	3.36e-07	8.82e-06	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PIK3CA—lung cancer	3.35e-07	8.79e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HRAS—lung cancer	3.33e-07	8.74e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTEN—lung cancer	3.28e-07	8.59e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ENO1—lung cancer	3.26e-07	8.56e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP1A1—lung cancer	3.22e-07	8.44e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ERCC2—lung cancer	3.19e-07	8.37e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—lung cancer	3.19e-07	8.37e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CD—lung cancer	3.19e-07	8.36e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALB—lung cancer	3.15e-07	8.25e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PIK3CA—lung cancer	3.14e-07	8.22e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—EP300—lung cancer	3.12e-07	8.19e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AKT1—lung cancer	2.94e-07	7.72e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOA1—lung cancer	2.93e-07	7.68e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP2E1—lung cancer	2.93e-07	7.68e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HRAS—lung cancer	2.9e-07	7.61e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NQO1—lung cancer	2.9e-07	7.59e-06	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AKT1—lung cancer	2.86e-07	7.49e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CB—lung cancer	2.78e-07	7.29e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—lung cancer	2.78e-07	7.28e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOA1—lung cancer	2.76e-07	7.24e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—lung cancer	2.75e-07	7.22e-06	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AKT1—lung cancer	2.74e-07	7.18e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CG—lung cancer	2.67e-07	7.01e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CA—lung cancer	2.63e-07	6.89e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—STK11—lung cancer	2.61e-07	6.84e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—AKT1—lung cancer	2.56e-07	6.72e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—POMC—lung cancer	2.55e-07	6.68e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CA—lung cancer	2.54e-07	6.66e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CG—lung cancer	2.52e-07	6.61e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CREBBP—lung cancer	2.48e-07	6.5e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTP1—lung cancer	2.41e-07	6.33e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTEN—lung cancer	2.4e-07	6.3e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—POMC—lung cancer	2.4e-07	6.29e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CD—lung cancer	2.35e-07	6.17e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CAT—lung cancer	2.35e-07	6.16e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CREBBP—lung cancer	2.34e-07	6.13e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALB—lung cancer	2.32e-07	6.09e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CA—lung cancer	2.31e-07	6.06e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—EP300—lung cancer	2.29e-07	6e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCB1—lung cancer	2.29e-07	5.99e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TYMS—lung cancer	2.24e-07	5.89e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTM1—lung cancer	2.22e-07	5.82e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CD—lung cancer	2.22e-07	5.81e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALB—lung cancer	2.19e-07	5.74e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AKT1—lung cancer	2.15e-07	5.63e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP1A1—lung cancer	2.1e-07	5.52e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ERCC2—lung cancer	2.09e-07	5.47e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AKT1—lung cancer	2.07e-07	5.44e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CB—lung cancer	2.05e-07	5.37e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—lung cancer	2.03e-07	5.33e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CB—lung cancer	1.93e-07	5.06e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—lung cancer	1.91e-07	5.02e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AKT1—lung cancer	1.89e-07	4.95e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOA1—lung cancer	1.8e-07	4.73e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTEN—lung cancer	1.77e-07	4.64e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CA—lung cancer	1.69e-07	4.44e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—EP300—lung cancer	1.69e-07	4.43e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTEN—lung cancer	1.67e-07	4.38e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CG—lung cancer	1.65e-07	4.32e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—EP300—lung cancer	1.59e-07	4.17e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—POMC—lung cancer	1.57e-07	4.11e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CREBBP—lung cancer	1.53e-07	4.01e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CD—lung cancer	1.45e-07	3.8e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALB—lung cancer	1.43e-07	3.75e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AKT1—lung cancer	1.38e-07	3.63e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CB—lung cancer	1.26e-07	3.31e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—lung cancer	1.25e-07	3.28e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CA—lung cancer	1.25e-07	3.28e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CA—lung cancer	1.18e-07	3.09e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTEN—lung cancer	1.09e-07	2.86e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—EP300—lung cancer	1.04e-07	2.73e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AKT1—lung cancer	1.02e-07	2.68e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AKT1—lung cancer	9.62e-08	2.52e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CA—lung cancer	7.7e-08	2.02e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AKT1—lung cancer	6.29e-08	1.65e-06	CbGpPWpGaD
